Centanafadine Hydrochloride

N/A

Report date: 2026/04/14 20:00:15
NME

Base Information

Drug NameCentanafadine Hydrochloride
Drug Alias Name森他发定centanafadinecentanafadina赛他发定centanafadinum +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin reuptake inhibitorsDopamine reuptake inhibitorsNorepinephrine reuptake inhibitors
TargetsNorepinephrine transporterDopamine transporterSerotonin transporter
Therapy Area/IndicationsAttention Deficit Disorder with HyperactivityDepressive Disorder, MajorBinge-Eating Disorder +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesPuerto Rico +[6] 
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesEuthymics Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesOtsuka Pharmaceutical Development & Commercialization IncOtsuka Pharmaceutical Co LtdOtsuka Beijing Research Institute
Inactive CompaniesN/A
Active IndicationsAttention Deficit Disorder with HyperactivityDepressive Disorder, MajorBinge-Eating Disorder +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG